These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4189565)

  • 41. Glucocorticoids and joint destruction in rheumatoid arthritis.
    Deodhar AA; Woolf AD
    N Engl J Med; 1995 Dec; 333(23):1569-70. PubMed ID: 7477185
    [No Abstract]   [Full Text] [Related]  

  • 42. [Steroidpsychosis in otorhinolaryngology].
    Lange K; Leis S; Offergeld C
    Laryngorhinootologie; 2018 Feb; 97(2):118-120. PubMed ID: 29237182
    [No Abstract]   [Full Text] [Related]  

  • 43. Cannabis and psychosis: an update on course and biological plausible mechanisms.
    Linszen D; van Amelsvoort T
    Curr Opin Psychiatry; 2007 Mar; 20(2):116-20. PubMed ID: 17278907
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Evaluation of the oxyphenylbutazone prednisolone combination in patients with progressive chronic polyarthritis].
    Pérez Gil L
    Rev Esp Reum Enferm Osteoartic; 1974; 17(1):45-52. PubMed ID: 4826156
    [No Abstract]   [Full Text] [Related]  

  • 45. Prednisolone pharmacokinetics and steroid psychosis.
    Tomson CR; Venning MC
    Lancet; 1987 Jan; 1(8527):270-1. PubMed ID: 2880083
    [No Abstract]   [Full Text] [Related]  

  • 46. [Acute brain syndrome after mefloquine treatment].
    Rønn AM; Bygbjerg IC
    Ugeskr Laeger; 1994 Oct; 156(41):6044-5. PubMed ID: 7992450
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Psychoses in cortisone therapy].
    Roos W
    Med Welt; 1965 Sep; 38():2167-71. PubMed ID: 5862864
    [No Abstract]   [Full Text] [Related]  

  • 48. Clinical evaluation of corticoid administration of rheumatoid arthritis.
    Ballabio BC; Colombo B; Carrabba M
    Chronobiologia; 1974 Sep; 1 Suppl 1():388-93. PubMed ID: 4377965
    [No Abstract]   [Full Text] [Related]  

  • 49. [EEG in symptomatic psychoses].
    Penin H
    Nervenarzt; 1971 May; 42(5):242-52. PubMed ID: 5578340
    [No Abstract]   [Full Text] [Related]  

  • 50. [Relationships between acute toxic amphetamine psychosis and extensive hydrocephalus].
    Bental E; Sharf B; Alroi M
    Harefuah; 1969 Oct; 77(7):310-6. PubMed ID: 5397680
    [No Abstract]   [Full Text] [Related]  

  • 51. [Influence of sleep deprivation on experimental psilocybine-induced psychosis].
    Hanus H; Preiningerová O; Fryntová H
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1970; 13(3):Suppl 3:319+. PubMed ID: 5275651
    [No Abstract]   [Full Text] [Related]  

  • 52. Benefits of low-dose corticosteroids in rheumatoid arthritis.
    Cohen MD; Conn DL
    Bull Rheum Dis; 1997 Jun; 46(4):4-7. PubMed ID: 9188203
    [No Abstract]   [Full Text] [Related]  

  • 53. EEG control of a cortisone psychosis.
    Danielezyk W
    Electroencephalogr Clin Neurophysiol; 1970 Feb; 28(2):217. PubMed ID: 4189565
    [No Abstract]   [Full Text] [Related]  

  • 54. [EEG findings in cortisone psychoses--a retrospective study in 10 patients].
    Bleistein J; Bräunig P
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1989 Jun; 20(2):112-6. PubMed ID: 2503353
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Behavioral and EEG changes in the amphetamine model of psychosis.
    Ellinwood EH
    Adv Biochem Psychopharmacol; 1974; 12(0):281-97. PubMed ID: 4473181
    [No Abstract]   [Full Text] [Related]  

  • 56. [E.E.G. changes associated with lithium poisoning (author's transl)].
    Spatz R; Kugler J; Greil W; Lorenzi E
    Nervenarzt; 1978 Sep; 49(9):539-42. PubMed ID: 703906
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.